Paper422706
Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.
Sheppard M and 5 others. J Clin Endocrinol Metab, 1979. Cited by 201 papers, by iCite.
Cite this record
ConductScience Library. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. Papers, record 422706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422706
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Somatostatin | Major topic |
| Adult | |
| Female | |
| Half-Life | |
| Humans | |
| Kidney Failure, Chronic | |
| Kinetics | |
| Liver Diseases | |
| Male | |
| Metabolic Clearance Rate | |
| Middle Aged |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42123401 | Somatostatin and Its Analogues as Second-Line Treatments in Non-Neoplastic Conditions. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123401 | PubMed |
| 40542938 | More Than Three Decades After Discovery of the Neuroprotective Effect of PACAP, What Is Still Preventing Its Clinical Use? | J Mol Neurosci | 2025 | https://conductscience.org/library/papers/40542938 | PubMed |
| 38529270 | From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. | Ther Adv Med Oncol | 2024 | https://conductscience.org/library/papers/38529270 | PubMed |
| 37692299 | Vascular-related biomarkers in psychosis: a systematic review and meta-analysis. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37692299 | PubMed |
| 33329885 | Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia. | Ther Adv Endocrinol Metab | 2020 | https://conductscience.org/library/papers/33329885 | PubMed |
| 32887456 | Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy. | Molecules | 2020 | https://conductscience.org/library/papers/32887456 | PubMed |
| 29973528 | Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/29973528 | PubMed |
| 27399347 | N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/27399347 | PubMed |
| 27247538 | Enterocutaneous Fistula: Proven Strategies and Updates. | Clin Colon Rectal Surg | 2016 | https://conductscience.org/library/papers/27247538 | PubMed |
| 26884209 | AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26884209 | PubMed |
| 25880900 | The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35). | BMC Endocr Disord | 2015 | https://conductscience.org/library/papers/25880900 | PubMed |
| 24587133 | Comparative study of somatostatin-human serum albumin fusion proteins and natural somatostatin on receptor binding, internalization and activation. | PLoS One | 2014 | https://conductscience.org/library/papers/24587133 | PubMed |
| 24058344 | Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target? | Front Pharmacol | 2013 | https://conductscience.org/library/papers/24058344 | PubMed |
| 23485864 | Differential pulsatile secretagogue control of GH secretion in healthy men. | Am J Physiol Regul Integr Comp Physiol | 2013 | https://conductscience.org/library/papers/23485864 | PubMed |
| 22358499 | Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. | Diabetologia | 2012 | https://conductscience.org/library/papers/22358499 | PubMed |
| 22345429 | A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance. | J Appl Physiol (1985) | 2012 | https://conductscience.org/library/papers/22345429 | PubMed |
| 16984213 | Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiency. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16984213 | PubMed |
| 11878792 | Pancreatic surgical complications--the case for prophylaxis. | Gut | 2001 | https://conductscience.org/library/papers/11878792 | PubMed |
| 11878789 | Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. | Gut | 2001 | https://conductscience.org/library/papers/11878789 | PubMed |
| 9098878 | Extensive biliary excretion of the model opioid peptide [D-PEN2,5] enkephalin in rats. | Pharm Res | 1997 | https://conductscience.org/library/papers/9098878 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SST | 6750 | PubTator's text mining | https://conductscience.org/library/genes/6750 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/422706
GET https://conductscience.org/api/papers/v1/422706/cited_by?page=2